Catheter-associated urinary tract infections in adult intensive care units at a selected tertiary hospital, Addis Ababa, Ethiopia.
Adult
Anti-Bacterial Agents
/ pharmacology
Bacteria
Bacteriuria
/ microbiology
Candidiasis
/ complications
Catheters
/ adverse effects
Cross Infection
/ complications
Escherichia coli
Ethiopia
/ epidemiology
Female
Gram-Negative Bacteria
Humans
Intensive Care Units
Male
Microbial Sensitivity Tests
Tertiary Care Centers
Urinary Tract Infections
/ drug therapy
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
24
12
2021
accepted:
21
02
2022
entrez:
22
3
2022
pubmed:
23
3
2022
medline:
4
5
2022
Statut:
epublish
Résumé
Catheter-associated urinary tract infection is the leading cause of hospital-acquired infections. They remain the second most common healthcare-associated infection in critically sick patients. To determine the prevalence of catheter-associated urinary tract infection, the spectrum of etiological agents, antibiotic sensitivity profile of bacterial pathogens among adult patients admitted to intensive care units. Patients admitted to the intensive care unit of hospitals in Addis Ababa who were on urethral indwelling catheters for >48 hours from October 2020 to September 2021 were included in the study. Urine specimens were aseptically collected and processed as per standard protocols. Microorganisms were isolated, identified, and subjected to antibiotic susceptibility testing. In all 220 pateints included in the study development of significant bacteriuria/candiduria was not affected by sex, age, and prior antibiotic therapy. However, the length of stay in the intensive care unit was significantly associated with bacteriuria /candiduria (P-value < 0.001). The overall prevalence of bacteriuria/candiduria was 51.4% among which 21.0%, 19.1%, and 11.4% were bacteriuria, candiduria, and polymicrobial infections, respectively. About 138 organisms were recovered of which 79 (57.25%) were bacteria and 59 (42.75%) were yeast isolates. Acinetobacter species, Pseudomonas species, Klebsiella species E. coli, and Enterococcus species were the dominant bacterial isolates. Candida. albicans, Candida. krusei and Candida. tropicalis were the commonest yeasts. Many gram-negative bacterial isolates were resistant to ceftriaxone 36(94.7%), ampicillin 21(91.3%) followed by cefotaxime34(89.5%), amikacin (16.0%), nitrofurantoin (17.4%), meropenem (20.0%) and imipenem (20.0%). Out of 79 bacterial pathogens, 52(65.8%) were multiple antibiotic resistant of which 37(71.0%) were Gram-negative bacteria and 15(29%%) were Gram-positive bacteria. About 13(86.7%) isolates of Acinetobacter, all isolates of Klebsiella species (100%) and E. coli (100%) were multiple antibiotic-resistant. Out Of 18,10(55.56%), isolates of Enterococcus were multiple antibiotic-resistant. A very high prevalence of bacteriuria/ candiduria was demonstrated in this study. This warrants the establishment of multidimensional infection control approach on catheter associated urinary tract infection in ICU. In addition to high prevalence of candiduria, recovery of non-albicans candida species almost in equal proportion with candida albicans in the present study was an important finding as non-albicans candida species distinct to C. albicans are intrinsically resistant to the commonly used azole antifungal drugs in Ethiopia. The prevalence of rate MDR bacteria in our ICU particularly of E. coli, Klebsiella spp, Pseudomonas and Acetobacter spp was very high. In order to combat this problem, proper antibiotic policies should be formulated.
Sections du résumé
BACKGROUND
Catheter-associated urinary tract infection is the leading cause of hospital-acquired infections. They remain the second most common healthcare-associated infection in critically sick patients.
OBJECTIVE
To determine the prevalence of catheter-associated urinary tract infection, the spectrum of etiological agents, antibiotic sensitivity profile of bacterial pathogens among adult patients admitted to intensive care units.
MATERIALS AND METHODS
Patients admitted to the intensive care unit of hospitals in Addis Ababa who were on urethral indwelling catheters for >48 hours from October 2020 to September 2021 were included in the study. Urine specimens were aseptically collected and processed as per standard protocols. Microorganisms were isolated, identified, and subjected to antibiotic susceptibility testing.
RESULTS
In all 220 pateints included in the study development of significant bacteriuria/candiduria was not affected by sex, age, and prior antibiotic therapy. However, the length of stay in the intensive care unit was significantly associated with bacteriuria /candiduria (P-value < 0.001). The overall prevalence of bacteriuria/candiduria was 51.4% among which 21.0%, 19.1%, and 11.4% were bacteriuria, candiduria, and polymicrobial infections, respectively. About 138 organisms were recovered of which 79 (57.25%) were bacteria and 59 (42.75%) were yeast isolates. Acinetobacter species, Pseudomonas species, Klebsiella species E. coli, and Enterococcus species were the dominant bacterial isolates. Candida. albicans, Candida. krusei and Candida. tropicalis were the commonest yeasts. Many gram-negative bacterial isolates were resistant to ceftriaxone 36(94.7%), ampicillin 21(91.3%) followed by cefotaxime34(89.5%), amikacin (16.0%), nitrofurantoin (17.4%), meropenem (20.0%) and imipenem (20.0%). Out of 79 bacterial pathogens, 52(65.8%) were multiple antibiotic resistant of which 37(71.0%) were Gram-negative bacteria and 15(29%%) were Gram-positive bacteria. About 13(86.7%) isolates of Acinetobacter, all isolates of Klebsiella species (100%) and E. coli (100%) were multiple antibiotic-resistant. Out Of 18,10(55.56%), isolates of Enterococcus were multiple antibiotic-resistant.
CONCLUSIONS
A very high prevalence of bacteriuria/ candiduria was demonstrated in this study. This warrants the establishment of multidimensional infection control approach on catheter associated urinary tract infection in ICU. In addition to high prevalence of candiduria, recovery of non-albicans candida species almost in equal proportion with candida albicans in the present study was an important finding as non-albicans candida species distinct to C. albicans are intrinsically resistant to the commonly used azole antifungal drugs in Ethiopia. The prevalence of rate MDR bacteria in our ICU particularly of E. coli, Klebsiella spp, Pseudomonas and Acetobacter spp was very high. In order to combat this problem, proper antibiotic policies should be formulated.
Identifiants
pubmed: 35316286
doi: 10.1371/journal.pone.0265102
pii: PONE-D-21-40524
pmc: PMC8939826
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0265102Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Int J Crit Illn Inj Sci. 2018 Jan-Mar;8(1):17-21
pubmed: 29619335
Intensive Crit Care Nurs. 2017 Jun;40:26-34
pubmed: 28237090
Eur J Clin Microbiol Infect Dis. 2001 Apr;20(4):260-2
pubmed: 11399016
Am J Med. 2002 Jul 8;113 Suppl 1A:5S-13S
pubmed: 12113866
BMC Womens Health. 2018 Jun 15;18(1):94
pubmed: 29902998
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Epidemiol Infect. 2015 Feb;143(3):653-62
pubmed: 24762978
J Infect. 2004 Oct;49(3):248-52
pubmed: 15337343
Clin Infect Dis. 2005 Sep 15;41 Suppl 6:S371-6
pubmed: 16108001
J Egypt Public Health Assoc. 2021 Mar 29;96(1):7
pubmed: 33779849
Anaesthesiol Intensive Ther. 2016;48(1):1-6
pubmed: 26966105
Mem Inst Oswaldo Cruz. 2005 Dec;100(8):925-8
pubmed: 16444426
Int J Environ Res Public Health. 2019 Jun 26;16(13):
pubmed: 31247907
Am J Infect Control. 2011 Mar;39(2):135-40
pubmed: 21176996
Cleve Clin J Med. 2013 Apr;80(4):225-33
pubmed: 23547093
Crit Care. 2005 Apr;9(2):R60-5
pubmed: 15774051
Saudi Med J. 2011 May;32(5):489-94
pubmed: 21556470
Clin Microbiol Rev. 2001 Oct;14(4):933-51, table of contents
pubmed: 11585791
Clin Infect Dis. 2009 Sep 1;49(5):682-90
pubmed: 19622043
Am J Surg. 1999 Apr;177(4):287-90
pubmed: 10326844
Int J Nurs Pract. 2007 Dec;13(6):348-53
pubmed: 18021163
Infect Ecol Epidemiol. 2014 Oct 01;4:
pubmed: 25317262
Am J Infect Control. 2013 Oct;41(10):885-91
pubmed: 23623158
Semin Respir Crit Care Med. 2006 Jun;27(3):310-24
pubmed: 16791763
Eur Urol. 2002 May;41(5):483-9
pubmed: 12074789
Clin Infect Dis. 2000 Jan;30(1):14-8
pubmed: 10619726
Intensive Care Med. 2003 Jul;29(7):1069-76
pubmed: 12756441
Infect Control Hosp Epidemiol. 2011 Aug;32(8):748-56
pubmed: 21768757
Mycoses. 2002 Oct;45(8):306-12
pubmed: 12572720
PLoS Med. 2016 Oct 18;13(10):e1002150
pubmed: 27755545
Med Sci Monit. 2011 Feb 25;17(3):PH17-22
pubmed: 21358613